Customer Center
Login | Register

GASTROINTESTINAL DISEASE

Flexible, Cost-effective Testing Options That Deliver Timely Results

Gastrointestinal Disease Portfolio

 

From targeted assays for C. difficile to broad disease state panels covering community-acquired and persistent diarrhea pathogens, clinical labs need flexibility and scalability in their GI assays to deliver optimal results to physicians for patient care, antimicrobial stewardship, and infection control.

 

That’s why Luminex offers targeted diagnostic options for nosocomial diarrhea and syndromic panels for community acquired/traveler’s diarrhea that align with recommended guidelines. These molecular solutions offer improved clinical outcomes when compared to traditional culture methods. In addition, the flexibility empowers clinical laboratories to improve efficiency by reducing turnaround time, consolidating sample testing, and reducing opportunities for human error. Overall, these solutions can help clinical labs generate actionable results while reducing costs.

 

Our gastrointestinal testing platforms are scalable to fit low-volume labs, high-capacity reference labs, and everything in between.

 

Learn more about our gastrointestinal disease testing options:

Targeted

Syndromic

 

Which Test is Right for You?
Category Targeted
(Nosocomial Diarrhea)
Syndromic
(Community-Acquired / Persistent Diarrhea)
Assay ARIES® C. difficile Assay xTAG™ GPP RUO 胃腸病原体検出キット
Instruments ARIES® Systems MAGPIX®
Luminex® 100/200™
Pathogens 1 15
Turnaround Time
(approximate)
2 hours 5 hours
Hands-on Time
(approximate)
3 minutes
per sample
7 minutes
per 24 samples
Throughput Low – Medium High
  Learn More Learn More

 

 

 

Gastrointestinal Disease Resources:

 

Rapid Diagnostics are Essential in the Battle Against Drug ResistanceOnline Article


Clinical Labs Streamline GI Testing with MDxMLO Online Article


Fecal Matters: Clinician and Laboratorian Perspective on Impact of Molecular GI Pathogen TestingWebinar

本製品は研究用試薬です。体外診断用医薬品としての使用はできません。